iTeos Therapeutics to Present at Cowen 40th Annual Health Care Conference

February 24, 2020

Cambridge, MA  and Gosselies, Belgium – February 24, 2020 – iTeos Therapeutics SA, a privately-held biotechnology company developing innovative cancer immunotherapies, today announced that Michel Detheux, Ph.D., president and chief executive officer, will present at the upcoming Cowen 40th Annual Health Care Conference on Monday, March 2, 2020 at 3:30 p.m. ET in Boston, MA

 

For further information, please contact:

Michel Detheux, CEO
iTeos Therapeutics
info@iteostherapeutics.com 
 
Amber Fennell, Catherine Day, Matthew Neal and Sukaina Virji 
Consilium Strategic Communications
+44 203 709 5700
iteos@consilium-comms.com 
 
Sarah McCabe
Stern Investor Relations, Inc.
+1 212 362 1200
sarah.mccabe@sternir.com